4//SEC Filing
Cunningham, Richard Anthony 4
Accession 0000899243-22-031348
CIK 0001537917other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:00 PM ET
Size
10.5 KB
Accession
0000899243-22-031348
Insider Transaction Report
Form 4
Cunningham, Richard Anthony
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−2,000,000→ 0 totalExercise: $1.03Exp: 2030-11-24→ Common Stock (2,000,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−500,000→ 0 totalExercise: $1.43Exp: 2031-06-13→ Common Stock (500,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−1,326,000→ 0 totalExercise: $0.33Exp: 2032-04-24→ Common Stock (1,326,000 underlying)
Footnotes (3)
- [F1]This option was fully vested and assumed by Syros Pharmaceuticals, Inc. ("Syros") in its merger with the issuer and replaced with an option to purchase 87,640 shares of Syros common stock for $23.51 per share, after giving effect to a 1-for-10 reverse stock split by Syros (the "Reverse Split").
- [F2]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 21,910 shares of Syros common stock for $32.63 per share, after giving effect to the Reverse Split.
- [F3]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 58,105 shares of Syros common stock for $7.53 per share, after giving effect to the Reverse Split.
Documents
Issuer
TYME TECHNOLOGIES, INC.
CIK 0001537917
Entity typeother
Related Parties
1- filerCIK 0001624783
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:00 PM ET
- Size
- 10.5 KB